Momenta Pharmaceuticals Inc. (MNTA) Declined -5.84% or -1.25 To Price $20.15 On Wednesday


Momenta Pharmaceuticals Inc. (MNTA) declined -5.84% or -1.25 to $20.15. It is nearly 228372 shares traded, which is 46.29% compare to the average total volume 493340. The market cap of MNTA is $1.56 billion. The year to date change is 43.29%. The 52 week price range is from $11.85 to $24.9. Price of MNTA have changed -4.04% during last week. It have changed -6.14% over last month, 25.15% over last 3 months, 60.90% over last 6 months and 17.91% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MNTA is 22.14. It is 9.88% above current price. The 200-day Moving Averages for MNTA is 17.24. It is -14.44% below current price. The 52-week High is 24.9. It is 23.57% from the current price. The 52-week Low is 11.85. It is -41.19% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MNTA is 7.7 on 2018-05-31. Short % to float is 6.80%. There are some statistics of MNTA. It is has market cap $1.56 billion. The share outstanding is 77.59 million. The average volume is 493340. The revenue is 47.66M. The percent of top 15 Institution holding is 95.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MNTA is -29.51%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MNTA is -22.21%.


Tags:

Share this post